Skip to main content

Table 2 List of systems/processes associated with genes in the amplified region as identified by IPA

From: Chromosome 15q11-q13 copy number gain detected by array-CGH in two cases with a maternal methylation pattern

Category

p-values

Molecules encoded from duplicated region

Auditory and Vestibular System Development and Function

2.20E-03

GABRA5,GABRB3

Auditory Disease

2.20E-03 - 8.41E-03

GABRA5,GABRB3

Behaviour

1.36E-03

GABRB3

Cancer

1.07E-02 - 4.42E-04

ATP10A,MKRN3,SNRPN,UBE3A

Cardiac Arteriopathy

4.33E-03

GABRA5,GABRB3,GABRG1,GABRG3

Cardiovascular Disease

4.33E-03 - 4.44E-08

GABRA5,GABRB3,GABRG1,GABRG3

Cell cycle

1.02E-02 - 4.42E-04

HERC2, UBE3A

Cell Death and Survival

3.03E-03 - 1.17E-03

GABRA5,GABRB3

Cell Morphology

2.68E-04 - 1.08E-02

OCA2, GABRA5,GABRB3,NDN

Cell-To-Cell Signalling and Interaction

1.57E-01 - 8.12E-03

NDN, UBE3A

Cellular Assembly and Organization

1.02E-02 - 7.54E-03

SNURF

Cellular Compromise

3.36E-05 - 1.72E-03

GABRA5,GABRB3

Cellular Development

8.05E-03 - 3.36E-05

NDN, UBE3A

Cellular Growth and Proliferation

8.05E-03 - 5.96E-04

NDN, UBE3A

Cellular Movement

2.68E-04 - 1.51E-04

GABRA5,GABRB3,NDN

Connective Tissue Development and Function

1.57E-01

NDN

Connective Tissue Disorders

1.40E-03 - 1.40E-08

GABRA5,GABRB3,GABRG3

Developmental Disorder

1.17E-02 - 4.69E-10

GABRB3,GABRG3,MAGEL2,MKRN3,NDN,SNRPN,UBE3A

DNA Replication, Recombination, and Repair

1.15E-02

SNRPN

Endocrine System Disorders

8.57E-03

MKRN3

Gene Expression

1.15E-02 - 6.35E-05

NDN,SNRPN,UBE3A

Hair and Skin Development and Function

4.97E-03

OCA2

Hematological Disease

5.83E-03

UBE3A

Hepatic System Development and Function

1.57E-01

NDN

Hereditary Disorder

1.17E-02 - 4.69E-10

GABRA5,GABRB3,GABRG3,MAGEL2,MKRN3,NDN,SNRPN, UBE3A

Infectious Disease

4.68E-05

GABRA5,GABRB3,GABRG3

Kidney Failure

2.45E-01

GABRB3

Liver Fibrosis

1.57E-01

NDN

Nervous System Development and Function

8.12E-03 - 1.51E-04

GABRA5,GABRB3,NDN, UBE3A

Neurological Disease

1.17E-02 - 5.59E-09

GABRA5,GABRB3,GABRG3,UBE3A

Nutritional Disease

1.82E-03 - 3.03E-06

GABRA5,GABRB3,GABRG3

Organ Morphology

5.87E-03 - 2.20E-03

GABRA5,GABRB3, UBE3A

Organismal Functions

5.87E-03

NDN

Organismal Injury and Abnormalities

2.45E-01 - 3.74E-06

GABRA5,GABRB3,GABRG3

Protein Degradation

1.33E-03

UBE3A

Protein Synthesis

1.33E-03

UBE3A

Psychological Disorders

5.57E-04 - 1.34E-06

GABRA5,GABRB3,GABRG3,NDN

Renal and Urological Disease

2.45E-01

GABRB3

Reproductive System Development

4.07E-03

UBE3A

Reproductive System Disease

8.57E-03 - 5.87E-03

MKRN3, UBE3A

Respiratory Disease

1.07E-02 - 5.97E-04

GABRA5,GABRB3,GABRG3, MKRN3, SNRPN

Skeletal and Muscular Disorders

8.12E-03 - 1.40E-08

GABRA5,GABRB3,GABRG3

Tissue Morphology

5.26E-06 - 8.57E-03

GABRA5,GABRB3,UBE3A

  1. Abbreviation: IPA ingenuity pathway analysis.